Ulotaront Phase III Schizophrenia Setback For Sumitomo, Otsuka Alliance

'High Placebo Response'

 
• By Ian Haydock
Ulotaron's Phase III DIAMOND 1 and 2 studies missed the primary endpoints
ulotaront misses target in two Phase III trials • Source: Shutterstock

More from R&D

More from Scrip